Role of PML and PML-RARα in Mad-mediated transcriptional repression

被引：123

作者：

Khan, MM

Nomura, T

Kim, H

Kaul, SC

Wadhwa, R

Shinagawa, T

Ichikawa-Iwata, E

Zhong, S

Pandolfi, PP

Ishii, S ^{[1
]}

机构：

[1] Cornell Univ, Grad Sch Med Sci, Dept Human Genet,Sloan Kettering Div, Mol Biol Program,Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[2] RIKEN, Tsukuba Inst, Genet Mol Lab, Tsukuba, Ibaraki 3050074, Japan

[3] JST, CREST, Res Project, Tsukuba, Ibaraki 3050074, Japan

[4] Natl Inst Biosci & Human Technol, Agcy Ind Sci & Technol, Tsukuba, Ibaraki 3050046, Japan

[5] Chugai Res Inst Mol Med, Ibaraki, Osaka 3004101, Japan

来源：

MOLECULAR CELL | 2001年 / 7卷 / 06期

关键词：

D O I：

10.1016/S1097-2765(01)00257-X

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Fusion of the promyelocytic leukemia (PML) protein to the retinoic acid receptor-alpha (RAR alpha) generates the transforming protein of acute promyelocytic leukemias. PML appears to be involved in multiple functions, including apoptosis and transcriptional activation by RAR, whereas PML-RAR alpha blocks these functions of PML. However, the mechanisms of leukemogenesis by PML-RAR alpha remain elusive. Here we show that PML interacts with multiple corepressors (c-Ski, N-CoR, and mSin3A) and histone deacetylase 1, and that this interaction is required for transcriptional repression mediated by the tumor suppressor Mad. PML-RAR alpha has the two corepressor-interacting sites and inhibits Mad-mediated repression, suggesting that aberrant binding of PML-RAR alpha to the corepressor complexes may lead to abrogation of the corepressor function. These mechanisms may contribute to events leading to leukemogenesis.

引用

页码：1233 / 1243

页数：11

共 34 条

[21] Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation [J].

Minucci, S ;

Maccarana, M ;

Cioce, M ;

De Luca, P ;

Gelmetti, V ;

Segalla, S ;

Di Croce, L ;

Giavara, S ;

Matteucci, C ;

Gobbi, A ;

Bianchini, A ;

Colombo, E ;

Schiavoni, I ;

Badaracco, G ;

Hu, X ;

Lazar, MA ;

Landsberger, N ;

Nervi, C ;

Pelicci, PG .

MOLECULAR CELL, 2000, 5 (05) :811-820

[22] PML, A GROWTH SUPPRESSOR DISRUPTED IN ACUTE PROMYELOCYTIC LEUKEMIA [J].

MU, ZM ;

CHIN, KV ;

LIU, JH ;

LOZANO, G ;

CHANG, KS .

MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) :6858-6867

[23]

NAGASE T, 1993, J BIOL CHEM, V268, P13710

[24] Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase [J].

Nagy, L ;

Kao, HY ;

Chakravarti, D ;

Lin, RJ ;

Hassig, CA ;

Ayer, DE ;

Schreiber, SL ;

Evans, RM .

CELL, 1997, 89 (03) :373-380

[25] Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor [J].

Nomura, T ;

Khan, MM ;

Kaul, SC ;

Dong, HD ;

Wadhwa, R ;

Colmenares, C ;

Kohno, I ;

Ishii, S .

GENES & DEVELOPMENT, 1999, 13 (04) :412-423

[26] PML induces a novel caspase-independent death process [J].

Quignon, F ;

De Bels, F ;

Koken, M ;

Feunteun, J ;

Ameisen, JC ;

de Thé, H .

NATURE GENETICS, 1998, 20 (03) :259-265

[27] The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice [J].

Shinagawa, T ;

Dong, HD ;

Xu, M ;

Maekawa, T ;

Ishii, S .

EMBO JOURNAL, 2000, 19 (10) :2280-2291

[28] Transcriptional repression by the promyelocytic leukemia protein, PML [J].

Vallian, S ;

Gäken, JA ;

Trayner, ID ;

Gingold, EB ;

Kouzarides, T ;

Chang, KS ;

Farzaneh, F .

EXPERIMENTAL CELL RESEARCH, 1997, 237 (02) :371-382

[29] Pml is essential for multiple apoptotic pathways [J].

Wang, ZG ;

Ruggero, D ;

Ronchetti, S ;

Zhong, S ;

Gaboli, M ;

Rivi, R ;

Pandolfi, PP .

NATURE GENETICS, 1998, 20 (03) :266-272

[30] RETINOIC ACID REGULATES ABERRANT NUCLEAR-LOCALIZATION OF PML-RAR-ALPHA IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS [J].

WEIS, K ;

RAMBAUD, S ;

LAVAU, C ;

JANSEN, J ;

CARVALHO, T ;

CARMOFONSECA, M ;

LAMOND, A ;

DEJEAN, A .

CELL, 1994, 76 (02) :345-356

← 1 2 3 4 →